Stockreport

PepGen muscular dystrophy drug gets ‘surprise' hold from FDA [Yahoo! Finance]

PepGen Inc.  (PEPG) 
PDF Dive Brief: PepGen is in a holding pattern on its request to include U.S. patients in a Phase 2 trial of a muscle disorder treatment after the Food and Drug Administr [Read more]